News / Press Releases

: Press Releases

Press Releases

Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19

July 13, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia

July 10, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

July 7, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Enrollment of Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia is Ahead of Schedule

June 29, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Results from Preclinical Study of TNX-1700 Presented in a Poster at AACR Virtual Annual Meeting 2020

June 22, 2020 • 9:00 AM EDT

Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID-19 Vaccine Collaboration

June 18, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Announces that Results from Preclinical Studies of TNX-1700 Will be Presented in a Poster at the AACR Virtual Annual Meeting 2020

June 17, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Acquisition of Non-Addictive Migraine and Pain Treatment Programs from Trigemina and Assumption of License

June 11, 2020 • 2:43 PM EDT

Tonix Pharmaceuticals Announces Appointment of Richard H. Bagger to Board of Directors

June 10, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences

June 3, 2020 • 7:00 AM EDT

« Previous
1
2
3
4
5
6
7
8
9
10
...35
Next »

Show All